Xcopri — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11 (month) in 3mo
ESTIMATED |
READOUT
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age
Phase 3 · Partial Epilepsy |
SK Life Science, Inc. | Xcopri |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|